JW ShinYak Lozartan Tablet (Losartan Potassium)
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.
MFDS item code 200500302 · Notified 2005.10.28
This product's status changed to Approval withdrawn on 2023.06.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used for the treatment of hypertension and is particularly helpful in preventing and treating kidney disease in type 2 diabetes patients. In other words, it effectively controls blood pressure, reducing cardiovascular risk and protecting kidney function. This efficacy contributes to improving the overall health status of patients.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be given orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. 4) Patients with reduced effective intravascular volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics) (see the Precautions for Use section). 5) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this drug alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; the dose may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; the dose may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by patients with certain conditions, such as severe liver impairment or hereditary angioedema. Elderly patients or those with reduced kidney function, and those with hyperkalemia should use this medication with caution, and blood pressure and kidney function should be frequently monitored. While this medication is generally safe, various side effects such as muscle cramps, dizziness, and upper respiratory infections may occur, so consult with a doctor if abnormal symptoms arise. Severe allergic reactions or angioedema can occasionally occur, so if swelling of the lips or face or difficulty breathing occurs, seek treatment immediately. This medication may affect liver and kidney function, so patients with liver or kidney disease need dosage adjustments and regular check-ups. There may be interactions with other drugs, so if you are taking other medications, be sure to inform healthcare providers, especially avoiding concomitant use with potassium-sparing diuretics or potassium supplements. During the course of this medication, blood pressure may drop too low, so if symptoms of dizziness or fainting occur, inform healthcare providers immediately. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication and should avoid it while breastfeeding. This medication is not to be used in children, especially those under 6 years old or those with severely impaired kidney function. In case of an overdose, hypotension and bradycardia may occur, so be cautious not to exceed the recommended dose, and seek medical attention if abnormal symptoms arise. This medication should be stored out of reach of children, and care should be taken not to transfer it to other containers as this could cause accidents or affect quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.